Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
60.13
-1.23 (-2.00%)
At close: Sep 5, 2025, 4:00 PM
60.00
-0.13 (-0.22%)
After-hours: Sep 5, 2025, 7:50 PM EDT
Guardant Health Employees
As of December 31, 2024, Guardant Health had 2,021 total employees, including 1,999 full-time and 22 part-time employees. The number of employees increased by 242 or 13.60% compared to the previous year.
Employees
2,021
Change (1Y)
242
Growth (1Y)
13.60%
Revenue / Employee
$410,118
Profits / Employee
-$204,759
Market Cap
7.50B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,021 | 242 | 13.60% |
Dec 31, 2023 | 1,779 | -14 | -0.78% |
Dec 31, 2022 | 1,793 | 420 | 30.59% |
Dec 31, 2021 | 1,373 | 509 | 58.91% |
Dec 31, 2020 | 864 | 242 | 38.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GH News
- 1 day ago - Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test - Business Wire
- 8 days ago - Guardant Health to Host Investor Day on September 24, 2025 - Business Wire
- 10 days ago - Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Business Wire
- 21 days ago - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 4 weeks ago - American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity - Business Wire
- 5 weeks ago - Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 5 weeks ago - Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings - Benzinga